Filtered By:
Condition: Babies Heart Conditions

This page shows you your search results in order of date.

Order by Relevance | Date

Total 141 results found since Jan 2013.

What Prohibition Can Teach Us About Drug and Alcohol Policy Today
It’s widely understood today that drinking while pregnant is harmful for the fetus. But the link between alcohol and the health of infants wasn’t as well known in the 1930s, when prohibition was repealed in the U.S. and all sorts of people, pregnant women included, began drinking again.Because prohibition was lifted on a piecemeal basis across the U.S., some counties continued to prohibit alcohol, or stay “dry,” while their neighboring counties were “wet.” Those conditions created what economists call a natural experiment, and made it possible to track the health impacts of maternal drin...
Source: TIME: Health - August 2, 2023 Category: Consumer Health News Authors: Oliver Staley Tags: Uncategorized Public Health Source Type: news

Daily Baby Aspirin Raises Odds for Brain Bleeds, With No Lowering of Stroke Risk
THURSDAY, July 27, 2023 -- For years, older adults took a baby aspirin a day to help ward off a first-time heart attack or stroke. Now yet another study is showing the risks are not worth it for most. Specifically, researchers found the risk of...
Source: Drugs.com - Daily MedNews - July 27, 2023 Category: General Medicine Source Type: news

Testosterone Treatments Aren ’ t Linked to Heart Risks When Patients Are Carefully Monitored, Study Finds
Advertisements for treatments for “low T,” or low testosterone levels in middle-aged and older men, have led to spikes in demand. But the safety and legitimacy of those testosterone therapies hasn’t been clear. In a new study published in the New England Journal of Medicine and presented at the Endocrine Society’s annual meeting, researchers provide the most conclusive evidence yet that testosterone treatments appear to be safe for the heart and are not associated with an increased risk of certain heart-related events. In the study, led by researchers at the Cleveland Clinic, more than 5,200 men age...
Source: TIME: Health - June 16, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate heart health Source Type: news

Maternity ’s Most Dangerous Time: After New Mothers Come Home
Recent research shows that most pregnancy-related deaths occur in the year after a baby is born. The discovery is changing how doctors care for new mothers.
Source: NYT Health - May 28, 2023 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Pregnancy and Childbirth Maternal Mortality Black People Heart Suicides and Suicide Attempts Women and Girls Babies and Infants Anxiety and Stress Diabetes Research Depression (Mental) Hypertension Stroke Deat Source Type: news

When does life end? New organ donation strategy fuels debate
On a chilly holiday Monday in January 2020, a medical milestone passed largely unnoticed. In a New York City operating room, surgeons gently removed the heart from a 43-year-old man who had died and shuttled it steps away to a patient in desperate need of a new one. More than 3500 people in the United States receive a new heart each year. But this case was different—the first of its kind in the country. “It took us 6 months to prepare,” says Nader Moazami, surgical head of heart transplantation at New York University (NYU) Langone Health, where the operation took place. The run-up included oversight from an ethi...
Source: ScienceNOW - May 11, 2023 Category: Science Source Type: news

New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Your Houseplants Have Some Powerful Health Benefits
Every morning, I spring out of bed, eager to check on my housemates: Alvin the monstera albo, Allison the other albo, Dominic the philodendron domesticum variegated, and Connie the Thai constellation monstera. Yes, my vegetal friends all have names—which you understand if you’re a plant person, too. Collecting and caring for houseplants boomed in popularity during the pandemic, especially among younger adults who often don’t have abundant outdoor space. Americans spent $8.5 billion more on gardening-related items in 2020 than in 2019, according to the U.S. Census Bureau. Vibrant communities blossomed on s...
Source: TIME: Health - March 2, 2023 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized healthscienceclimate Research Wellbeing Source Type: news

Stewardship for Science and Vaccines
Despite the success of vaccines in the modern world, including the rapid development of the COVID-19 vaccine, my state is now experiencing a large measles outbreak and a decline in immunization rates. At the turn of the century, the Centers for Disease Control and Prevention published “Ten Great Public Health Achievements” of the twentieth century in the United States.1 Vaccination topped the list, a national and global success story. Other achievements included improvements in motor-vehicle safety, control of infectious diseases, safer workplaces, decline in deaths from coro nary heart disease and stroke, safer and he...
Source: Pediatric Clinics of North America - February 24, 2023 Category: Pediatrics Authors: Tina L. Cheng Tags: Foreword Source Type: research

Unlucky numbers: Fighting murder convictions that rest on shoddy stats
LEIDEN, THE NETHERLANDS— When a Dutch nurse named Lucia de Berk stood trial for serial murder in 2003, statistician Richard Gill was aware of the case. But he saw no reason to stick his nose into it. De Berk was a pediatric nurse at Juliana Children’s Hospital in The Hague. In 2001, after a baby died while she was on duty, a colleague told superiors that De Berk had been present at a suspiciously high number of deaths and resuscitations. Hospital staff immediately informed the police. When investigators reexamined records from De Berk’s shifts, they found 10 suspicious incidents. Three other hospitals where D...
Source: Science of Aging Knowledge Environment - January 19, 2023 Category: Geriatrics Source Type: research

AHA News: Days Before Christmas, New Mom Had a Stroke
THURSDAY, Dec. 22, 2022 (American Heart Association News) -- Two weeks after giving birth and a week before Christmas 2016, Ashley Hammontree was enjoying a snowy day at home in Greenwood, Missouri. Wearing pajamas, she nursed her baby, Elijah, and...
Source: Drugs.com - Daily MedNews - December 22, 2022 Category: General Medicine Source Type: news

Umbilical cord thrombosis and chorioamnionitis in neonatal arterial ischaemic stroke
A baby boy was delivered at term by emergency caesarean section because of abnormal fetal heart rate patterns during spontaneous labour. The umbilical cord arterial blood obtained at delivery had a pH of 6.97 and a lactate concentration of 12.1 mmol/L. The Apgar scores were 3 and 7, respectively, at 1 and 5 min. The proximal umbilical cord had a thrombotic aspect at delivery (figure 1). A thrombus was also identified in the ductus venosus at 1 hour of life. The boy presented left hemicorporeal seizures at 21 hours of life, which revealed a neonatal arterial ischaemic stroke (NAIS; figure 2). Placental histology revealed ac...
Source: Archives of Disease in Childhood - Fetal and Neonatal Edition - December 15, 2022 Category: Perinatology & Neonatology Authors: Dridi, M., Chabrier, S., Raia-Barjat, T., Giraud, A. Tags: Open access Images in neonatal medicine Source Type: research

Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Cold Weather Can Be Dangerous for the Human Body. This Winter Worries Experts
A particularly nasty trifecta of influenza, COVID-19, and respiratory syncytial virus (RSV) is already portending a rough winter. But there’s another factor contributing to a potentially tough season for health: a colder-than-average season, which is forecast in the northern U.S. and the U.K. Even an ordinary cold season can pose a threat to human health and safety. One 2015 study published in the Lancet analyzed over 74 million deaths around the world found that more than 7% of deaths were attributed to exposure to cold temperatures. “There is conclusive evidence that there is increased risk for many health ou...
Source: TIME: Health - November 15, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized healthscienceclimate Public Health Wellbeing Source Type: news

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Decreasing rates of cost-related medication non-adherence by age advancement among American generational cohorts 2004-2014: a longitudinal study
Conclusion The paradox of decreasing CRN rates, independent of disease burden, income and insurance status, suggests populations’ CRN behaviours change as Americans age, bearing implications to social policy.
Source: BMJ Open - May 6, 2022 Category: General Medicine Authors: Zhang, J., Bhaumik, D., Meltzer, D. Tags: Open access, Health economics Source Type: research